- Home
- SCNI vs PTIX Comparison
SCNI vs PTIX Comparison
Compare SCNI & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- PTIX
- Stock Information
- Founded
- SCNI 2003
- PTIX 1994
- Country
- SCNI Israel
- PTIX United States
- Employees
- SCNI N/A
- PTIX N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- SCNI Health Care
- PTIX Health Care
- Exchange
- SCNI Nasdaq
- PTIX Nasdaq
- Market Cap
- SCNI 3.5M
- PTIX 3.9M
- IPO Year
- SCNI N/A
- PTIX 2016
- Fundamental
- Price
- SCNI $2.84
- PTIX $0.64
- Analyst Decision
- SCNI
- PTIX
- Analyst Count
- SCNI 0
- PTIX 0
- Target Price
- SCNI N/A
- PTIX N/A
- AVG Volume (30 Days)
- SCNI 12.9K
- PTIX 247.6K
- Earning Date
- SCNI 11-29-2024
- PTIX 11-29-2024
- Dividend Yield
- SCNI N/A
- PTIX N/A
- EPS Growth
- SCNI N/A
- PTIX N/A
- EPS
- SCNI N/A
- PTIX N/A
- Revenue
- SCNI $284,000.00
- PTIX N/A
- Revenue This Year
- SCNI N/A
- PTIX N/A
- Revenue Next Year
- SCNI N/A
- PTIX N/A
- P/E Ratio
- SCNI N/A
- PTIX N/A
- Revenue Growth
- SCNI N/A
- PTIX N/A
- 52 Week Low
- SCNI $2.23
- PTIX $0.49
- 52 Week High
- SCNI $8.92
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- SCNI 30.31
- PTIX 49.61
- Support Level
- SCNI $2.91
- PTIX $0.52
- Resistance Level
- SCNI $3.70
- PTIX $1.09
- Average True Range (ATR)
- SCNI 0.21
- PTIX 0.15
- MACD
- SCNI -0.07
- PTIX 0.01
- Stochastic Oscillator
- SCNI 7.37
- PTIX 20.91
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.